Abijah is a person named in the Old Testament. She was the daughter of a Zechariah, possibly Zechariah the son of Jeberechiah (2 Chr. 29:1; compare Isa. 8:2), and afterwards the wife of King Ahaz and mother of King Hezekiah. She is also called Abi (2 Kings 18:2).
Some writers consider that Abijah is the almah or virgin (at the time of the prophecy) in the Immanuel prophecy in Isaiah 7:14, and that the child who will be an infant when Rezin and Pekah are defeated by Tiglath Pileser III may be the future heir, Hezekiah.
ABI gene family member 3 (ABI3) also known as new molecule including SH3 (Nesh) is a protein that in humans is encoded by the ABI3 gene.
This gene encodes a member of an adaptor protein family. Members of this family encode proteins containing a homeobox homology domain, proline rich region and Src-homology 3 (SH3) domain. The encoded protein inhibits ectopic metastasis of tumor cells as well as cell migration. This may be accomplished through interaction with p21-activated kinases.
Protein-bound paclitaxel, also known as nanoparticle albumin–bound paclitaxel or nab-paclitaxel, is an injectable formulation of paclitaxel used to treat breast cancer, lung cancer and pancreatic cancer, among others. Paclitaxel destroys cancer cells by preventing the normal breakdown of microtubules during cell division. In this formulation, paclitaxel is bonded to albumin as a delivery vehicle. It is manufactured and sold in the United States by Abraxis BioScience under the trade name Abraxane where it is designated as an orphan drug as first-line treatment, in combination with gemcitabine, for the orphan disease "metastatic adenocarcinoma of the pancreas."
This treatment was approved by the U.S. Food and Drug Administration (FDA) in January 2005 and the European Medicines Agency in January 2008 for breast cancer cases where cancer did not respond to other chemotherapy or has relapsed. In June 2010, positive results were published from a phase III trial in first-line non-small-cell lung cancer (NSCLC) when compared with solvent-based paclitaxel, and in October 2012 the FDA widened the approved use of Abraxane to include treatment for NSCLC. In September 2013, the FDA approved Abraxane for use in treating advanced pancreatic cancer as a less toxic (although less effective) alternative to FOLFIRINOX.
Zen+ is the codename for an AMD microarchitecture that will eventually succeed Zen. According to AMD, Zen+ is expected to bring a slight increase in instructions per clock over Zen, but not nearly as large as the jump from Excavator to Zen.
The Zenú or Sinú is an Amerindian tribe in Colombia, whose ancestral territory comprises the valleys of the Sinu and San Jorge rivers as well as the coast of the Caribbean around the Gulf of Morrosquillo. These lands lie within the departments of Córdoba and Sucre.
The Zenú culture existed from about 200 BCE to about 1600 CE, constructing major water works and producing gold ornaments. The gold that was often buried with their dead lured the Spanish conquerors, who looted much of the gold. With the arrival of the Spaniards, the tribe all but died out. The 16th-century Spanish chroniclers wrote about the Zenú who were still living there, but recorded little or nothing about the history of the Zenú.
In 1966 the geographer James Parsons drew attention to rake-like patterns that were visible on aerial photographs of the wetlands in the lower reaches of the river San Jorge, patterns that could not have arisen naturally. Ten years later a major reconstructive research started.
Özen is a Turkish name, it may refer to: